On January 15, 2025, the Food and Drug Administration approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC).
fda.gov
fda.gov
RSS Hunter
2025-01-16
Create attached notes ...